(Q44292749)

1 December 2017

title

FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma (English)

1 reference

1 December 2017

FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphoma (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

28 May 2024

1

P. L. Zinzani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589345

28 May 2024

author name string

M. Bendandi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589345

28 May 2024

S. Tura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589345

28 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7589345

28 May 2024

publication date

1 October 1995

1 reference

full work available at URL

1 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0609.1995.tb00269.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0609.1995.tb00269.x

28 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

European Journal of Haematology

28 May 2024

published in

1 reference

1 December 2017

volume

55

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

262-266

1 reference

The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma

1 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors

28 May 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

28 May 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

28 May 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

28 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

28 May 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

28 May 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

28 May 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma

28 May 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

28 May 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Updated Kiel classification for lymphomas

28 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Toxicity and response criteria of the Eastern Cooperative Oncology Group

28 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma

28 May 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

28 May 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

28 May 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma

28 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells

28 May 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells

28 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.1995.TB00269.X

28 May 2024

Identifiers

0 references

1 reference